Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
TRAW
Traws Pharma, Inc.
CAPPED RATING
Traws Pharma, Inc. (TRAW) is rated D+ (1.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B+); its weakest is Profitability (D-).
Quantitative Factor Evaluation • Updated
Overall Rating
1.8
/ 5.0
D+
Value
B+
Factor Score
3.7
/ 5.0
Growth
D
Factor Score
1.2
/ 5.0
Profitability
D-
Factor Score
0.8
/ 5.0
Momentum
D-
Factor Score
0.8
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
-0.1
EV / EBITDA
0.1
Rev Growth YoY
N/A
Gross Margin
0.0%
Price Return 3M
-53.7%
Price Return 12M
-88.3%
Catalyst Signal
0.00
Market Cap
$3.9M
TTM Revenue
$0.0
Price / Sales
N/A
ROE
-433.4%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-15 | B+ (3.7) | D (1.2) | D- (0.8) | D- (0.8) | C+ (2.6) | D+ (1.8) |
| 2026-11-08 | A- (3.9) | D (1.2) | D- (0.8) | F (0.7) | C+ (2.6) | D+ (1.8) |
| 2026-11-01 | B+ (3.7) | D (1.2) | D- (1.0) | D (1.2) | C+ (2.7) | C- (1.9) |
| 2026-10-25 | C+ (2.5) | D (1.2) | D- (0.9) | D (1.2) | C+ (2.6) | D+ (1.7) |
| 2026-10-18 | C+ (2.5) | D (1.2) | D- (0.9) | D- (1.1) | C+ (2.6) | D+ (1.7) |
Page
1
of
3